子類別 報告 [0/1] 專利 [0/11] 期刊論文 [193/194] 會議論文/會議摘要 [41/48] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:0(0.00%) 含全文筆數:234(92.13%) 文件下載次數統計 下載大於0次:234(100.00%) 下載大於100次:234(100.00%) 檔案下載總次數:146965(2.74%) 最後更新時間: 2024-12-01 08:22 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目51-75 / 254. (共11頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2016-06	IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma	Molecular Oncology. 2016 Jun;10(6):895-909.
2016-05	Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma	Molecular Carcinogenesis. 2016 May;55(5):499-513.
2016-03	miR-520h is crucial for DAPK2 regulation and breast cancer progression	Oncogene. 2016 Mar 3;35(9):1134-1142.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2016-01	The role of wnt signaling in squamous cell carcinoma	Journal of Dental Research. 2016 Jan;95(2):129-134.
2016-01	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition	Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.
2015-12	Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model	European Journal of Medicinal Chemistry. 2015 Dec;106:60-74.
2015-10	Integrating image-based high-content screening with mouse models identifies 5-hydroxydecanoate as a neuroprotective drug for paclitaxel-induced neuropathy	Molecular Cancer Therapeutics. 2015 Oct ;14(10):2206-2214.
2015-09	O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma	International Journal of Cancer. 2015 Sep;137(6):1291-1305.
2015-08	Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes	Bioorganic and Medicinal Chemistry. 2015 Aug;23(15):4230-4236.
2015-08	Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway	Chemical Research in Toxicology. 2015 Aug ;28(9):1681-1692.
2015-08	MPT0B292 enhances acetylation of alpha-tubulin through up-regulation of acetyltransferase gene, MEC-17 and exhibits potent anti-tumor, anti-angiogenesis and anti-metastatic effects in vitro and in vivo	Cancer Research. 2015 Aug;75(Suppl. 15):Abstract number 4379.
2015-07	Alcohol drinking obliterates the inverse association between serum retinol and risk of head and neck cancer	Medicine. 2015 Jul;94(26):Article number e1064.
2015-06-01	Autophagy-regulated ROS from xanthine oxidase acts as an early effector for triggering late mitochondria-dependent apoptosis in cathepsin S-targeted tumor cells	PLoS ONE. 2015 Jun 1;10(6):Article number e0128045.
2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	Annals of Oncology. 2015 May;26(5):943-949.
2015-05	Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo	Biochemical Pharmacology. 2015 May;95(1):28-37.
2015-05	Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595.
2015-04	The role of miR-450a in oral squamous cell carcinoma carcinogenesis	FASEB Journal. 2015 Apr;29(1, Suppl.):Abstract number 711.22.
2015-03	Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer	Oral Diseases. 2015 Mar;21(2):207-215.
2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
2015-01	YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells	British Journal of Pharmacology. 2015 Jan;172(1):214-234.
2014-12-15	Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b	Cancer Research. 2014 Dec 15;74(24):7560-7572.
2014-12	Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer	International Journal of Cancer. 2014 Dec;135(12):2760-2769.
2014-11	The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer	International Journal of Cancer. 2014 Nov;135(10):2424-2436.
2014-11	CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors	European Journal of Cancer. 2014 Nov;50(Suppl. 6):19-20.

顯示項目51-75 / 254. (共11頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目